如何通过健康技术评估来支持中国国家药品报销目录的药品调出。
How health technology reassessment can support disinvestment in China's national drug reimbursement list.
机构信息
Department of Health Policy and Management, School of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana, USA
Pharmacoeconomics Committee, Association of Health Economics of Beijing, Beijing.
出版信息
BMJ. 2023 Jun 15;381:e068917. doi: 10.1136/bmj-2021-068917.
Abstract
A requirement to assess actual use of reimbursed medicines would enable transparent, documented, evidence based decisions on disinvestment, say
摘要
评估已报销药品的实际使用情况的要求，可以使基于证据的透明决策和撤资决策有文件记录可查，相关人员说道。
Zotero 插件